proteomic-based diagnostics
SomaLogic Q1 Revenues Grow 22 Percent
The Boulder, Colorado-based protein analysis company missed the consensus Wall Street revenue estimate but beat it on the bottom line.
Genoox, Aspira Women's Health Partner to Develop New MDx Technologies
The firms seek to apply AI and machine learning to improve diagnosis and treatment of conditions including ovarian and pelvic diseases.
Biodesix Q2 Revenues Shoot up but Fall Short of Wall Street Expectations
COVID-19 testing revenues grew to $6.0 million while lung diagnostic revenues rose to $4.8 million and biopharma revenues increased to $1.0 million.
Vermillion Eyes $17M in Public Offering of Stock
The firm expect to raise gross proceeds of $15 million, or $17.25 million if the offering's underwriter exercises its option to purchase additional shares.
The four-protein signature is associated with early forms of colon cancer that are most likely to progress into later stages of the disease.
Mar 20, 2019
Nov 7, 2018
Sep 14, 2018
Jul 12, 2018
Dec 8, 2017
Nov 8, 2017
Vermillion Q3 Revenues Up 12 Percent
Sep 26, 2017